Novel Use of N-Acetylcysteine in Management of Tyrosine Kinase Inhibitor Induced Acute Liver Injury

Cureus
doi 10.7759/cureus.6251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

N-Acetylcysteine Treatment in Viral-Induced Acute Liver Failure

International Journal of Clinical Trials
2019English

A Novel Nanoscale Formulation of Hydrophobic SRC Tyrosine Kinase Inhibitor PP2 Prevents Pulmonary Ischemia Reperfusion Induced Acute Lung Injury

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

A Case Report on Role of N-Acetylcysteine in Non–acetaminophen Related Acute Liver Injury

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2016English

Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice

Alcoholism: Clinical and Experimental Research
MedicinePsychiatryMental HealthToxicology
2016English

P11 Tyrosine Kinase Inhibitor Use in Pulmonary Adenocarcinoma

Thorax
PulmonaryRespiratory Medicine
2013English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

PWE-130 Effect of N Acetylcysteine (NAC) in Hypoxia Induced Liver Injury (HILI)–A Randomized Placebo Control Clinical Trial

Gut
Gastroenterology
2013English

Complications Associated With Perioperative Use of Tyrosine Kinase Inhibitor in Cytoreductive Nephrectomy

Scientific Reports
Multidisciplinary
2019English

N-Acetylcysteine Is Effective for Prevention but Not for Treatment of Folic Acid-Induced Acute Kidney Injury in Mice*

Critical Care Medicine
Critical CareIntensive Care Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy